What to Expect From Baxter International’s Next Quarterly Earnings Report

Deerfield, Illinois-based Baxter International Inc. (BAX) is a global healthcare technology company specializing in essential hospital and renal-care products like IV solutions, infusion systems, and dialysis therapies. With a market cap of $11.8 billion, its operations span globally, distributing products through direct sales and a network of distributors across many countries. The med-tech giant is expected to announce its fiscal third-quarter earnings before the market opens on Thursday, Oct. 30.

Ahead of the event, analysts expect BAX to report a profit of $0.60 per share on a diluted basis, down 25% from $0.80 per share in the year-ago quarter. The company has surpassed Wall Street’s EPS estimates in three of the last four quarterly reports, while missing on another occasion.